Friday, June 26, 2020 8:27:11 PM
Favs agreement went through on April 3.
In the 10Q it states that Favs accounted for $8,003,396 in revenue and also 32% of accounts receivable (meaning it was most likely an order placed right before 4/30 and not yet paid hence why it's not considered revenue yet), so another $1,028,450. Total orders of $9M between 4/3 and 4/30.
Assuming $9M/month times 12 months we'd be at $108M for the year through Favs. If they stay around 36% of the overall revenue, which I'd suspect it won't as more larger distributors start picking up Bidi Sticks, then we'd be at a minimum of $300M revenue for the year overall (assuming minimal to no growth month over month).
For a comparison, Juul generated $2B in revenue in 2018. In July 2018 it was valued at roughly $15B, and by December 2018 it was valued at $38B while estimating $3.4B in revenue for 2019, so roughly a 7-10x revenue multiple.
At $300M sales our valuation could be in the $2.1Billion to $3Billion range, and based on our O/S, we're looking at a PPS of $3.67 - $5.24.
Now, the real fun happens if they move any of the common shares to preferred to lower the O/S. If the O/S gets cut in half, the public float would be 11.5% (good enough for OTCQB) and our share price would be $7.3 to $10.5 to match the valuations above.
Just something to think!
"Everything in existence is based on exact proportion and perfect relationship. There is no chance in nature, because mathematical principles of the highest order lie at the foundation of all things. There is nothing in the Universe but mathematical point
Recent KAVL News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/29/2024 09:20:56 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/20/2024 12:48:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/14/2024 09:05:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/14/2024 08:58:47 PM
- Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:15:33 PM
- Kaival Brands Provides Business Update in Letter to Shareholders • GlobeNewswire Inc. • 02/14/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:54:48 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/29/2024 10:10:18 PM
- Kaival Brands Partner Bidi Vapor to Contest FDA Denial of ‘Classic’ Tobacco-Flavored ENDS • GlobeNewswire Inc. • 01/29/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:14:06 PM
- Kaival Brands Innovations Group Announces Reverse Stock Split • GlobeNewswire Inc. • 01/23/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 02:00:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/16/2024 05:15:25 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 01/12/2024 10:21:13 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/12/2024 02:59:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:15:44 PM
- Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President • GlobeNewswire Inc. • 12/28/2023 01:30:00 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/22/2023 01:00:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/12/2023 09:16:14 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/12/2023 09:05:37 PM
- Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel • GlobeNewswire Inc. • 12/07/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:31:02 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM